DoseGear research brief
Enhanced derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approved in Russia since early 2000s.
DG Peptide Protocols
EmergingCognitiveLongevity
Adalank
N-Acetyl Selank Amidate
N-Acetyl Selank Amidate | Enhanced Tuftsin Analog
Research overview
Mechanism of action
Modulates GABAergic neurotransmission, upregulates hippocampal BDNF, influences serotonin metabolism, and provides immunomodulatory effects without benzodiazepine-like dependency.
Compound background
Development & research timeline
Study windows describe what researchers measured, not when an individual should expect a result.
Origin & development
Described as a modified Selank derivative; a specific developer is not established in the reviewed source.
What it is researched for
Proposed anxiety and cognition research based on Selank-like GABAergic and neurotrophic activity; derivative-specific validation is limited.
Research observation window
Not reported in the reviewed compound-specific evidence. The cited 14-day anxiety trial concerns Selank, not Adalank.
Reference data
Lyophilized vial injectable protocols
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Anxiety Reduction | 200-300mcg | 1x daily (morning) | SubQ |
| Cognitive Enhancement | 200-500mcg | 1x daily | SubQ |
| Stress Management | 200-300mcg | 2x daily (morning, afternoon) | SubQ |
| Initial Trial | 100-200mcg | 1x daily | SubQ |
Reference cycle
2-4 weeks
Reference storage
Lyophilized: room temp or freezer; Reconstituted: 2-8°C for 14-30 days
Safety context
Reported side effects
- Parent compound has high safety profile in Russian clinical research
- Minimal side effects reported
Contraindications & cautions
- Experimental peptide with limited direct human research on N-Acetyl form
- Not recommended during pregnancy or breastfeeding
- Consult healthcare provider before use with psychiatric medications
Scientific references
- 01
Selank for GAD - Non-inferiority Trial
Scientific citationSelank for GAD - Non-inferiority Trial. . - 02
Selank and BDNF Regulation in Hippocampus
Scientific citationSelank and BDNF Regulation in Hippocampus. . - 03
Peptide Selank Enhances Diazepam Effects
Scientific citationPeptide Selank Enhances Diazepam Effects. .
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.